Regeneron’s Ebola treatment proves superior to rival in trial
(Reuters) – Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Regeneron/Sanofi cut heart drug price to $4,500-$6,600 for Express Scripts
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts…